| Ident. | Authors (with country if any) | Title |
|---|
| 000045 (2020) |
Jean-Luc Cracowski [France] ; Mathieu Molimard [France] ; Vincent Richard [France] | Ultrafast response of the French Society of Pharmacology and Therapeutics to the COVID-19 pandemic. |
| 000049 (2020) |
Sophie Amrane [France] ; Hervé Tissot-Dupont [France] ; Barbara Doudier [France] ; Carole Eldin [France] ; Marie Hocquart [France] ; Morgane Mailhe [France] ; Pierre Dudouet [France] ; Etienne Ormières [France] ; Lucie Ailhaud [France] ; Philippe Parola [France] ; Jean-Christophe Lagier [France] ; Philippe Brouqui [France] ; Christine Zandotti [France] ; Laetitia Ninove [France] ; Léa Luciani [France] ; Céline Boschi [France] ; Bernard La Scola [France] ; Didier Raoult [France] ; Matthieu Million [France] ; Philippe Colson [France] ; Philippe Gautret [France] | Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot. |
| 000050 (2020) |
François Montastruc [France] ; Charles Romano [France] ; Jean-Louis Montastruc [France] ; Stein Silva [France] ; Thierry Seguin [France] ; Vincent Minville [France] ; Bernard Georges [France] ; Béatrice Riu-Poulenc [France] ; Olivier Fourcade [France] | Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France. |
| 000051 (2020) |
Jean-Christophe Lagier [France] ; Matthieu Million [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Sébastien Cortaredona [France] ; Audrey Giraud-Gatineau [France] ; Stéphane Honoré [France] ; Jean-Yves Gaubert [France] ; Pierre-Edouard Fournier [France] ; Hervé Tissot-Dupont [France] ; Eric Chabrière [France] ; Andreas Stein [France] ; Jean-Claude Deharo [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Alexis Jacquier [France] ; Bernard La Scola [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Philippe Parola [France] ; Didier Raoult [France] | Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. |
| 000052 (2020) |
Joëlle Micallef [France] ; Thomas Soeiro [France] ; Annie-Pierre Jonville-Béra [France] | Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection. |
| 000053 (2020) |
David Lebeaux [France] ; Matthieu Revest [France] | No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France". |
| 000054 (2020) |
S. Neveu [France] ; I. Saab [France] ; S. Dangeard [France] ; S. Bennani [France] ; M. Tordjman [France] ; G. Chassagnon [France] ; M-P Revel [France] | Incidental diagnosis of Covid-19 pneumonia on chest computed tomography. |
| 000056 (2020) |
Joachim Alexandre [France] ; Jean-Luc Cracowski [France] ; Vincent Richard [France] ; Béatrice Bouhanick [France] | Drugs acting on renin angiotensin system and use in ill patients with COVID-19. |
| 000057 (2020) |
Philippe Gautret [France] ; Philippe Colson [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Didier Raoult [France] | Does spitting in public play a role in transmitting SARS-CoV-2? |
| 000058 (2020) |
Béatrice Bouhanick [France] ; Jean-Luc Cracowski [France] ; Jean-Luc Faillie [France] | Diabetes and COVID-19. |
| 000059 (2020) |
Luciana K. Tanno [France] ; Thomas Casale [États-Unis] ; Pascal Demoly [France] | Coronavirus Disease (COVID)-19: World Health Organization Definitions and Coding to Support the Allergy Community and Health Professionals. |
| 000060 (2020) |
M. Roustit [France] ; R. Guilhaumou [France] ; M. Molimard [France] ; M-D Drici [France] ; S. Laporte [France] ; J-L Montastruc [France] | Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence. |
| 000061 (2020) |
Isabelle Lacroix [France] ; Justine Bénévent [France] ; Christine Damase-Michel [France] | Chloroquine and hydroxychloroquine during pregnancy: What do we know? |
| 000062 (2020) |
C. Jalaber [France] ; T. Lapotre [France] ; T. Morcet-Delattre [France] ; F. Ribet [France] ; S. Jouneau [France] ; M. Lederlin [France] | Chest CT in COVID-19 pneumonia: A review of current knowledge. |
| 000063 (2020) |
Lucile Grange [France] ; Philippe Guilpain [France] ; Marie-Elise Truchetet [France] ; Jean-Luc Cracowski [France] | Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review. |
| 000064 (2020) |
Maryse Lapeyre-Mestre [France] ; Alexandra Boucher [France] ; Amélie Daveluy [France] ; Valérie Gibaja [France] ; Emilie Jouanjus [France] ; Michel Mallaret [France] ; Helene Peyrière [France] ; Joëlle Micallef [France] | Addictovigilance contribution during COVID-19 epidemic and lockdown in France. |
| 000065 (2020) |
Alexandre Gérard [France] ; Serena Romani [France] ; Audrey Fresse [France] ; Delphine Viard [France] ; Nadège Parassol [France] ; Aurélie Granvuillemin [France] ; Laurent Chouchana [France] ; Fanny Rocher [France] ; Milou-Daniel Drici [France] | "Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers. |
| 000068 (2020) |
Erwan Sallard [France] ; José Halloy [France] ; Didier Casane [France] ; Jacques Van Helden [France] ; Étienne Decroly [France] | [Tracing the origins of SARS-COV-2 in coronavirus phylogenies]. |
| 000069 (2020) |
Sara Salinas [France] ; Yannick Simonin [France] | [Neurological damage linked to coronaviruses : SARS-CoV-2 and other human coronaviruses]. |
| 000070 (2020) |
Frédéric Iseni [France] ; Jean-Nicolas Tournier [France] | [A race against the clock: creation of SARS-Cov-2 in the laboratory, a month after its emergence!] |
| 000071 (2020) |
Bernard I. Lévy [France] ; Jean-Pierre Fauvel [France] | Renin-angiotensin system blockers and severe acute respiratory syndrome coronavirus 2. |
